[1]高 营,孙 伟.加巴喷丁治疗酒依赖的临床疗效[J].医学信息,2019,32(17):142-144.[doi:10.3969/j.issn.1006-1959.2019.17.047]
　GAO Ying,SUN Wei.Clinical Efficacy of Gabapentin in the Treatment of Alcohol Dependence[J].Journal of Medical Information,2019,32(17):142-144.[doi:10.3969/j.issn.1006-1959.2019.17.047]
点击复制

加巴喷丁治疗酒依赖的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年17期
页码:
142-144
栏目:
药物与临床
出版日期:
2019-09-01

文章信息/Info

Title:
Clinical Efficacy of Gabapentin in the Treatment of Alcohol Dependence
文章编号:
1006-1959（2019）17-0142-03
作者:
高 营; 孙 伟
天津市安定医院物质成瘾科，天津 300222
Author(s):
GAO Ying; SUN Wei
Department of Material Addiction,Tianjin Anding Hospital,Tianjin 300222,China
关键词:
加巴喷丁; 酒依赖; 强制性酒精问卷; 宾夕法尼亚酒精渴求; 心理渴求; 复饮
Keywords:
Key words：Gabapentin; Alcohol dependence; Mandatory alcohol questionnaire; Pennsylvania alcohol craving; Psychological craving; Relapsed drink
分类号:
R9
DOI:
10.3969/j.issn.1006-1959.2019.17.047
文献标志码:
A
摘要:
目的 观察加巴喷丁治疗酒精依赖的临床疗效。方法 选取2018年2月~2019年2月我院收治的酒依赖患者82例，采用随机数字表法分为加巴喷丁组和安慰剂组，每组41例。加巴喷丁组予加巴喷丁胶囊治疗，安慰剂组予无药物成分的模拟胶囊治疗，比较两组治疗前和治疗后2、4、8、12周强制性饮酒问卷（OCDS）、宾夕法尼亚酒精渴求量表（PACS）及副反应量表（TESS）评分。结果 治疗后2周，加巴喷丁组OCDS、PACS评分与安慰剂组比较，差异无统计学意义（P＞0.05）；治疗后4、8、12周，加巴喷丁组OCDS评分、PACS评分低于安慰剂组[（52.64±1.56）分vs（53.68±1.86）分、（18.62±5.22）分vs（24.34±5.65）分]、[（49.31±1.32）分vs（51.62±1.93）分、（15.14±4.15）分vs（23.92±4.86）分]、[（46.52±1.43）分vs（51.62±1.93）分、（14.71±5.67）分vs（23.92±4.86）分]，差异有统计学意义（P＜0.05）；治疗后4、8、12周，两组TESS评分比较，差异无统计学意义（P＞0.05）。结论 加巴喷丁可有效减少饮酒行为，降低渴求度，且耐受性好，不良反应轻微。
Abstract:
Abstract：Objective To observe the clinical efficacy of gabapentin in the treatment of alcohol dependence.Methods A total of 82 patients with alcohol dependence who were admitted to our hospital from February 2018 to February 2019 were randomly divided into the gabapentin group and the placebo group, with 41 cases in each group. The gabapentin group was treated with gabapentin capsules, and the placebo group was treated with no drug-containing simulating capsules. The two groups were treated before and after the 2, 4, 8 and 12 weeks of mandatory drinking questionnaire (OCDS) and the Pennsylvania Alcohol Thirsty Scale (PACS) and the side reaction scale (TESS) score.Results At 2 weeks after treatment, the OCDS and PACS scores of the gabapentin group were not significantly different from those of the placebo group (P>0.05).At 4,8,and 12 weeks after treatment, the OCDS score and PACS score of the gabapentin group were lower than those of the placebo group[(52.64±1.56) points vs (53.68±1.86) points, (18.62±5.22) points vs (24.34±5.65) points], [(49.31±1.32) points vs (51.62±1.93) points, (15.14±4.15) points Vs (23.92±4.86) points], [(46.52±1.43) points vs (51.62±1.93) points, (14.71±5.67) points vs (23.92±4.86) points], the difference was statistically significant (P<0.05); At 4,8 and 12 weeks after treatment, the TESS scores of the two groups were not significantly different (P>0.05).Conclusion Gabapentin can effectively reduce alcohol consumption, reduce craving, and is well tolerated with mild adverse reactions.

参考文献/References:

[1]曹龙飞,周晓波,高哲,等.男性酒精依赖患者复饮相关因素研究[J].中国药物滥用防治杂志,2016,22(6):330-335. [2]Kumar J,Hapidin H,Bee YT,et al.Effects of the acute ethanol administration on ethanol withdrawal-induced anxiety-like syndrome in rats:A biochemicalstudy[J].Alcohol,2016,2(50):9-17. [3]熊峰,周毅,赵娟.神经递质及其受体在酒精诱导神经系统损伤中的作用[J].神经损伤与功能重建,2014,5(9):243-246. [4]付金玉.浅谈加巴喷丁在神经病理性疼痛的研究进展[J].医学理论与实践,2014,26(14):1851-1853. [5]徐亚辉,王瑛,刘晖.酒依赖患者神经肽Y与焦虑、抑郁及渴求的相关性[J].中国神经精神疾病杂志,2015,41(11):690-693 [6]Swift RM,Aston ER.Pharmacotherapy for Alcohol Use Disorder:Current and Emerging Therapies[J].Harv Rev Psychiatry,2015,23(2):122-133. [7]高贯峰,吉峰.酒依赖治疗的相关药物研究进展[J].中国农村医学,2019(5):29-31. [8]匡大志.酒依赖的药物治疗[J].中国实用医药,2014(23):207-208. [9]梁河.加巴喷丁临床应用研究进展[J].临床合理用药,2017,7(10):166-167. [10]Ayala-Guerrero F,Mexicano G,Gutiérrez-Chávez CA,et al.Effect of gabapentin on sleep patterns disturbed by epilepsy[J].Epilepsy&Behavior,2019(92):290-296. [11]Mason BJ,Quello S,Goodell V,et al.Gabapentin treatment for alcohol dependence:a randomized clinical trial[J].JAMA,2014(174):70-71. [12]Ahmed S,Bachu R,Kotapati P,et al.Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders:A Systematic Review[J].Front Psychiatry,2019(10):228. [13]Chompookham P,Rukngan W,Nilaban S,et al.A randomized trial of low-dose gabapentin for post hospitalization relapse prevention in a Thai clinical sample of alcohol dependence[J].Psychiatry Research,2018(9):34-40. [14]Falk DE,Ryan ML,Fertig JB,et al.Gabapentinenacarbil extended-release for alcohol use disorder:Arandomized,double-blind,placebo-controlled,multisite trial assessing efficacy and safety[J].Alcohol Clin Exp Res,2019,43(1)176-181. [15]丁艺,谢涵,葛卫红.对比普瑞巴林和加巴喷丁治疗带状疱疹后遗神经痛疗效和安全性的Meta分析[J].药学与临床研究,2019,27(1):57-59. [16]Eung JG,Hall-Flavin D,Nelson S,et al.The role of gabapentin in the management of alcohol withdrawal and dependence[J].Ann Pharmacother,2015,49(8):897-906.

相似文献/References:

[1]张春兰,谢 筠,李美娟.重复经颅磁刺激在酒依赖患者精神依赖治疗中的应用[J].医学信息,2018,31(15):37.[doi:10.3969/j.issn.1006-1959.2018.15.013]
　ZHANG Chun-lan,XIE Yun,Li Mei-juan.Application of Repetitive Transcranial Magnetic Stimulation in the Treatment of Mental Dependence in Patients with Alcohol Dependence[J].Journal of Medical Information,2018,31(17):37.[doi:10.3969/j.issn.1006-1959.2018.15.013]
[2]孟君艳.加巴喷丁联合盐酸羟考酮对晚期癌因性疼痛患者的效果及对其疼痛介质的影响[J].医学信息,2019,32(10):146.[doi:10.3969/j.issn.1006-1959.2019.10.048]
　MENG Jun-yan.Effect of Gabapentin Combined with Oxycodone Hydrochloride on Patients with Advanced Cancer-induced Pain and its Effect on Pain Media[J].Journal of Medical Information,2019,32(17):146.[doi:10.3969/j.issn.1006-1959.2019.10.048]

更新日期/Last Update: 2019-09-01